Default company panoramic image

SCILEX Laboratories

SCILEX Labs is a platform for converting genetic innovations into medical diagnostic tools. Improved Outcomes. Risk Mitigation. Revenue.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location Atlanta, GA, USA
  • Currency USD
  • Founded July 2012
  • Website

Company Summary

SCILEX is a genetics lab that develops medical testing applications for DNA sequencing. We're poised to revolutionize the standard for prescribing Opioid Analgesics, SSRIs, and other heavily prescribed medications. In essence, the Company’s DNA tests create a virtual cheat sheet for physicians prescribing high-risk medications. The Genetic Sequencing platform by SCILEX is to medicine what the App Store was to the mobile data explosion.


  • Default avatar
    Bryan Mack

    Mack earned the degree of Master of Business Administration 2003 and now serves as CEO of another successful medical technology company. He has developed strategic relationships nationally that now double as a launching platform for SCILEX. Previously, Mack played a key role in the launch and expansion of two other medical companies that pioneered first to market products & services. Each of those companies are now market leaders.

  • Default avatar
    Michael Shaffer

    Co-founder & President Michael Shaffer, a physicist by education, has more than 20 years of experience in business development. After many years as a successful equities trader, he came into the Healthcare market eventually launching a medical technology company. This provides a ready-made book of business for SCILEX as his existing national sales organization is poised to introduce the DNA testing applications.


  • Default avatar
    Perry & Young
    Default avatar
    Curtis J. Johnson, CPA

Previous Investors

  • Default avatar
    Kirby Collings
    Default avatar
    Harriette Reed
    Default avatar
    Jeremy Millirons